SanofiSNY
Price (close)
$40.94
Market cap
$99.4B
P/E
—
Revenue (FY)
—
Net income
$7.8B
Dividend yield
5.92%
1-year total return
-4.1%
Net margin
—
Revenue growth
—
Debt / equity
0.20x
What Sanofi does.
Sanofi’s activities are organized around the following categories within the Biopharma operating segment : Immunology, Rare
Several fundamental trends continue to point to a positive outlook for the pharmaceutical industry. The global population is
growing and ageing, and unmet medical needs remain high. Health needs have further increased, strengthening the key roles of
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | $12.3B | $6.2B | $8.4B | $5.4B | $5.6B | $7.8B |
More on SNY.
- Sanofi summary
- Sanofi financial statements
- Sanofi key metrics
- Sanofi health scores and style box
- Sanofi earnings
- Sanofi dividends
- Sanofi valuation
- Sanofi ownership and insiders
- Sanofi peers
Figures from Sanofi's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.